FHIR IG analytics| Package | ca.on.health.idms.agreementmvp |
| Resource Type | CodeSystem |
| Id | CS-Funding-Program.json |
| FHIR Version | R5 |
| Source | https://simplifier.net/resolve?scope=ca.on.health.idms.agreementmvp@3.0.10&canonical=https://health.gov.on.ca/idms/fhir/CodeSystem/Funding-Program |
| URL | https://health.gov.on.ca/idms/fhir/CodeSystem/Funding-Program |
| Version | 1.0.0 |
| Status | active |
| Date | 2025-11-28 |
| Name | Funding-Program |
| Title | IDMS - Funding-Program |
| Description | Funding Programs. These are used by 4 ValueSets. Submission Program: Multiple Source Drug Submissions->Generic Line Extenstion Funding Programs, Submission Committee Recommendation, Funding Designation, Agreement and Rebate Funding Program. |
| Content | complete |
No resources found
No resources found
No narrative content found in resource
{
"resourceType": "CodeSystem",
"id": "Funding-Program",
"meta": {
"versionId": "2",
"lastUpdated": "2025-12-01T16:25:31.329+00:00",
"source": "#0d9faddb3b6b41787d3ec39d64582c71"
},
"url": "https://health.gov.on.ca/idms/fhir/CodeSystem/Funding-Program",
"version": "1.0.0",
"name": "Funding-Program",
"title": "IDMS - Funding-Program",
"status": "active",
"date": "2025-11-28",
"publisher": "IDMS",
"description": "Funding Programs. These are used by 4 ValueSets. Submission Program: Multiple Source Drug Submissions->Generic Line Extenstion Funding Programs, Submission Committee Recommendation, Funding Designation, Agreement and Rebate Funding Program.",
"content": "complete",
"concept": [
{
"code": "GENERAL-BENEFIT",
"display": "General Benefit (GB)"
},
{
"code": "LIMITED-USE",
"display": "Limited Use (LU)"
},
{
"code": "EAP",
"display": "Exceptional Access Program (EAP)"
},
{
"code": "NDFP",
"display": "New Drug Funding Program (NDFP)"
},
{
"code": "SDP",
"display": "Special Drugs Program (SDP)"
},
{
"code": "IMD",
"display": "Inherited Metabolic Diseases (IMD) Program"
},
{
"code": "RSV",
"display": "Respiratory Syncytial Virus (RSV) Programs"
},
{
"code": "VISUDYNE",
"display": "Visudyne Program"
},
{
"code": "FACILITATED-ACCESS",
"display": "Facilitated Access"
},
{
"code": "OFI",
"display": "Off-Formulary Interchangeability (OFI)"
},
{
"code": "NUTRITIONAL-PRODUCT",
"display": "Nutrition Product (NP)"
},
{
"code": "DIABETIC",
"display": "Diabetic Testing Agent (DTA)"
},
{
"code": "VHC",
"display": "Valved Holding Chamber (VHC)"
},
{
"code": "FGM",
"display": "Continuous Glucose Monitoring (CGM) System"
},
{
"code": "NHP",
"display": "Natural Health Product (NHP)"
},
{
"code": "FAST",
"display": "Funding Accelerated Specific Treatments (FAST)"
},
{
"code": "PC",
"display": "Palliative Care (PC)"
},
{
"code": "TB",
"display": "Temporary Benefit (TB)"
},
{
"code": "Allergen",
"display": "Allergen"
},
{
"code": "ONPP",
"display": "Ontario Naloxone Program for Pharmacies (ONPP)"
},
{
"code": "OTHER",
"display": "Other (Miscellaneous)"
},
{
"code": "NO-FUNDING",
"display": "No Funding/Listing"
},
{
"code": "NON-FORMULARY",
"display": "Non-Formulary"
}
]
}